BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

781 related articles for article (PubMed ID: 7895220)

  • 1. Ovarian and endometrial cancers.
    Mant JW; Vessey MP
    Cancer Surv; 1994; 19-20():287-307. PubMed ID: 7895220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in incidence of and mortality from uterine and ovarian cancer in Mid and South Limburg, The Netherlands, 1986-2003.
    Kellert IM; Botterweck AA; Huveneers JA; Dirx MJ
    Eur J Cancer Prev; 2009 Feb; 18(1):85-9. PubMed ID: 19077569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian cancer incidence (1989-1991) and mortality (1954-1993) in The Netherlands.
    Koper NP; Kiemeney LA; Massuger LF; Thomas CM; Schijf CP; Verbeek AL
    Obstet Gynecol; 1996 Sep; 88(3):387-93. PubMed ID: 8752245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gynaecological cancers in Umbria (Italy): trends of incidence, mortality and survival, 1978-1998.
    Minelli L; Stracci F; Prandini S; Moffa IF; La Rosa F
    Eur J Obstet Gynecol Reprod Biol; 2004 Jul; 115(1):59-65. PubMed ID: 15223167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention.
    Bray F; Dos Santos Silva I; Moller H; Weiderpass E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1132-42. PubMed ID: 15894663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of HRT and the subsequent risk of cancer.
    Beral V; Banks E; Reeves G; Appleby P
    J Epidemiol Biostat; 1999; 4(3):191-210; discussion 210-5. PubMed ID: 10695959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Worldwide variations in the lifetime probability of reproductive cancer in women: implications of best-case, worst-case, and likely-case assumptions about the effect of oral contraceptive use.
    Petitti DB; Porterfield D
    Contraception; 1992 Feb; 45(2):93-104. PubMed ID: 1559340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends and differentials in ovarian cancer: incidence, mortality and survival experience.
    Hanai A
    APMIS Suppl; 1990; 12():1-20. PubMed ID: 2190628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cervical, endometrial and ovarian cancers among immigrants in Sweden: importance of age at migration and duration of residence.
    Beiki O; Allebeck P; Nordqvist T; Moradi T
    Eur J Cancer; 2009 Jan; 45(1):107-18. PubMed ID: 18829301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination oral contraceptives and cancer risk.
    Gast K; Snyder T
    Kans Med; 1990 Jul; 91(7):201-8. PubMed ID: 2202849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in the mortality (1950-1997) and incidence (1975-1993) of malignant ovarian neoplasm among Japanese women: analyses by age, time, and birth cohort.
    Tamakoshi K; Kondo T; Yatsuya H; Hori Y; Kikkawa F; Toyoshima H
    Gynecol Oncol; 2001 Oct; 83(1):64-71. PubMed ID: 11585415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use.
    dos Santos Silva I; Swerdlow AJ
    Br J Cancer; 1995 Aug; 72(2):485-92. PubMed ID: 7640237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age related trends in the incidence of endometrial cancer in South East England 1962-1997.
    Somoye G; Olaitan A; Mocroft A; Jacobs I
    J Obstet Gynaecol; 2005 Jan; 25(1):35-8. PubMed ID: 16147691
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality rates due to gynecologic cancers in New York state by demographic factors and proximity to a Gynecologic Oncology Group member treatment center: 1979-2001.
    Tan W; Stehman FB; Carter RL
    Gynecol Oncol; 2009 Aug; 114(2):346-52. PubMed ID: 19411096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in cervical cancer mortality in the Americas.
    Robles SC; White F; Peruga A
    Bull Pan Am Health Organ; 1996 Dec; 30(4):290-301. PubMed ID: 9041740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends in survival of patients diagnosed with cancers of the brain and nervous system, thyroid, eye, bone, and soft tissues in the Nordic countries 1964-2003 followed up until the end of 2006.
    Bray F; Engholm G; Hakulinen T; Gislum M; Tryggvadóttir L; Storm HH; Klint A
    Acta Oncol; 2010 Jun; 49(5):673-93. PubMed ID: 20192877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trends in cigarette sales and lung cancer mortality in four central European countries.
    Kubík A; Plesko I
    Cent Eur J Public Health; 1998 Feb; 6(1):37-41. PubMed ID: 9524740
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.